MX2013010031A - Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal. - Google Patents

Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal.

Info

Publication number
MX2013010031A
MX2013010031A MX2013010031A MX2013010031A MX2013010031A MX 2013010031 A MX2013010031 A MX 2013010031A MX 2013010031 A MX2013010031 A MX 2013010031A MX 2013010031 A MX2013010031 A MX 2013010031A MX 2013010031 A MX2013010031 A MX 2013010031A
Authority
MX
Mexico
Prior art keywords
health care
personal health
solid substrate
care applications
disintegratable solid
Prior art date
Application number
MX2013010031A
Other languages
English (en)
Other versions
MX341035B (es
Inventor
Trevor John Darcy
Steven Ray Gilbert
Robert Wayne Glenn Jr
Mark Edward Stella
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2013010031A publication Critical patent/MX2013010031A/es
Publication of MX341035B publication Critical patent/MX341035B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

Un artículo para el cuidado personal. Más particularmente, un artículo para el cuidado personal que comprende al menos un sustrato sólido desintegrable poroso; el artículo comprende: de aproximadamente 1 % a aproximadamente 70 %, en peso de dicho sustrato, de un surfactante, de aproximadamente 10 % a aproximadamente 70 %, en peso de dicho sustrato, de uno o más polímeros, de aproximadamente 0.025 % a aproximadamente 85 %, en peso de dicho sustrato, de uno o más activos para el cuidado de la salud, opcionalmente, un plastificante y, opcionalmente, un agente estético en donde dicho artículo es ingerible. La invención comprende, además, un proceso para elaborar un artículo para el cuidado personal.
MX2013010031A 2011-03-01 2012-03-01 Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal. MX341035B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161447738P 2011-03-01 2011-03-01
US201161447737P 2011-03-01 2011-03-01
PCT/US2012/027162 WO2012125297A1 (en) 2011-03-01 2012-03-01 Porous disintegratable solid substrate for personal health care applications

Publications (2)

Publication Number Publication Date
MX2013010031A true MX2013010031A (es) 2013-11-04
MX341035B MX341035B (es) 2016-08-03

Family

ID=45888478

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010031A MX341035B (es) 2011-03-01 2012-03-01 Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal.

Country Status (9)

Country Link
US (1) US9005635B2 (es)
EP (1) EP2680815B1 (es)
AU (1) AU2012229476B2 (es)
BR (1) BR112013020816A2 (es)
CA (1) CA2828747C (es)
ES (1) ES2610411T3 (es)
MX (1) MX341035B (es)
PL (1) PL2680815T3 (es)
WO (1) WO2012125297A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2803382C (en) 2010-07-02 2015-03-31 The Procter & Gamble Company Method for delivering an active agent
WO2012003351A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Web material and method for making same
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
US9592150B2 (en) * 2014-01-24 2017-03-14 William J. McNulty, Jr. Medical device for the treatment of hemorrhoids, tissue inflammation and other conditions
US9492594B2 (en) 2014-07-18 2016-11-15 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
US11406742B2 (en) 2014-07-18 2022-08-09 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
CA2973217A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery
US10898447B2 (en) * 2016-10-27 2021-01-26 Psirrros Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
US12329722B2 (en) * 2016-10-27 2025-06-17 Psimos, Inc. Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use
MX380853B (es) 2017-01-27 2025-03-12 Procter & Gamble Composiciones en la forma de estructuras solidas solubles
MX380727B (es) 2017-01-27 2025-03-12 Procter & Gamble Composiciones en la forma de estructuras sólidas solubles que comprenden partículas aglomeradas efervescentes.
CN107041495B (zh) * 2017-03-13 2020-12-01 天津科技大学 一种以nfc为主要技术的浆果花色苷饮品及其制备方法
US11235019B2 (en) 2017-04-12 2022-02-01 Artesa Llc Compositions and methods for treating traveler's diarrhea
CN110650723A (zh) 2017-05-16 2020-01-03 宝洁公司 可溶性固体结构形式的调理毛发护理组合物
WO2019153334A1 (zh) * 2018-02-12 2019-08-15 天津天狮生物发展有限公司 一种调节人体肠道功能的复合益生元及其应用
US12544446B2 (en) 2018-03-02 2026-02-10 Vitiprints, LLC Printed delivery device having supplements
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
EP4447893A1 (en) 2021-12-17 2024-10-23 The Procter & Gamble Company Dissolvable solid fibrous shampoo articles containing salts
WO2023173048A1 (en) 2022-03-10 2023-09-14 The Procter & Gamble Company Dissolvable solid structure having first and second layers
IT202200025521A1 (it) * 2022-12-13 2024-06-13 Neilos S R L “Composizione nutraceutica o farmaceutica comprendente un estratto di Pelargonium sidoides”
DE102023121256A1 (de) 2023-08-09 2025-02-13 Green IN Beauty UG (haftungsbeschränkt) Zusammensetzung zur Herstellung einer Zahnpflegetablette

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
DE19635676A1 (de) 1996-09-03 1998-03-05 Basf Ag Feste geschäumte Wirkstoffzubereitungen
KR0181252B1 (ko) * 1996-12-31 1999-03-20 박원훈 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
AU5062299A (en) 1998-07-21 2000-02-14 Alpenstock Holdings Limited Formulations of anionic polysaccharides
US6090401A (en) 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
AU2001281846B2 (en) 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
DE10032456A1 (de) 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
US6800668B1 (en) 2001-01-19 2004-10-05 Intellipharmaceutics Corp. Syntactic deformable foam compositions and methods for making
US20030072804A1 (en) 2001-03-19 2003-04-17 The Procter & Gamble Company Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
ATE376170T1 (de) 2001-04-20 2007-11-15 Glaxo Group Ltd Messmethode für teilchenmaterial
AU2003206382B2 (en) 2002-01-03 2008-01-24 Smithkline Beecham Corporation Novel pharmaceutical dosage forms and method for producing same
US6800295B2 (en) 2002-10-09 2004-10-05 The Dial Corporation Water soluble sheet composition
GB0401950D0 (en) 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
DE102005058569B4 (de) 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
US20100080829A1 (en) * 2007-04-11 2010-04-01 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
AU2008266060B2 (en) 2007-06-13 2013-08-29 Fmc Corporation Alginate coated, polysaccharide gel-containing foam composite, preparative methods, and uses thereof
KR100937625B1 (ko) * 2007-08-10 2010-01-20 주식회사 제닉 가용성 웹 공극필름 및 이의 제조방법
CA2710411A1 (en) 2007-10-19 2009-04-23 Bayer Materialscience Ag Process for the preparation of aromatized chewing foams for cosmetic products
US8765170B2 (en) * 2008-01-30 2014-07-01 The Procter & Gamble Company Personal care composition in the form of an article
EP2666457B1 (en) 2008-04-16 2020-06-17 The Procter & Gamble Company Process for forming a non-lathering personal care article in the form of a dissolvable solid foam
US8461090B2 (en) 2008-12-08 2013-06-11 The Procter & Gamble Company Personal care composition in the form of an article having a porous, dissolvable solid structure
BRPI0922379B1 (pt) 2008-12-08 2021-08-03 The Procter & Gamble Company Composição para cuidados pessoais na forma de um artigo que tem um revestimento hidrofóbico residente de superfície
CA2746317C (en) * 2008-12-08 2013-10-29 The Procter & Gamble Company Porous, dissolvable solid substrates and surface resident cyclodextrin perfume complexes
CN102245155B (zh) 2008-12-08 2015-11-25 宝洁公司 具有可溶性多孔固体结构的制品形式的个人护理组合物
BRPI0922333B1 (pt) 2008-12-08 2019-01-29 Procter & Gamble processo de produção de um artigo para dissolução mediante o uso da aplicação de tensoativos
CA2769636A1 (en) * 2009-07-30 2011-02-03 The Procter & Gamble Company Oral care articles and methods
US8309505B2 (en) 2009-07-30 2012-11-13 The Procter & Gamble Company Hand dish composition in the form of an article
US8367596B2 (en) 2009-07-30 2013-02-05 The Procter & Gamble Company Laundry detergent compositions in the form of an article
US8288332B2 (en) 2009-07-30 2012-10-16 The Procter & Gamble Company Fabric care conditioning composition in the form of an article
MX2012006247A (es) 2009-12-08 2012-06-19 Procter & Gamble Un sustrato solido soluble poroso y un recubrimiento fijo de superficie de acondicionador de surfactante cationico.
CN102647974B (zh) 2009-12-08 2014-03-12 宝洁公司 可溶性多孔固体基质和阳离子表面活性剂调理剂材料
CN102917683B (zh) 2009-12-08 2015-08-05 宝洁公司 可溶性多孔固体基质和包含水敏活性物质的表面驻留涂层
US20110132387A1 (en) 2009-12-08 2011-06-09 Ali Abdelaziz Alwattari Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Skin Treatment Active
WO2011072009A1 (en) 2009-12-08 2011-06-16 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres
WO2011103152A1 (en) 2010-02-16 2011-08-25 The Procter & Gamble Company A porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
MX2013000201A (es) * 2010-07-02 2013-08-21 Procter & Gamble Metodos para suministrar un activo de atencion sanitaria por medio de administrar articulos de cuidado personal que comprenden un filamento.
MX360481B (es) 2010-07-02 2018-11-05 Procter & Gamble Articulo con estructura soluble de trama fibrosa que comprende agentes activos.
BR112013000069B1 (pt) 2010-07-02 2021-04-20 The Procter & Gamble Company manta de não-tecido compreendendo pluralidade de filamentos com polímero, e agente ativo, bem como método para tratar artigo de tecido

Also Published As

Publication number Publication date
WO2012125297A1 (en) 2012-09-20
AU2012229476B2 (en) 2016-02-25
EP2680815B1 (en) 2016-08-17
CA2828747A1 (en) 2012-09-20
ES2610411T3 (es) 2017-04-27
MX341035B (es) 2016-08-03
AU2012229476A1 (en) 2013-09-12
US9005635B2 (en) 2015-04-14
CA2828747C (en) 2016-05-10
EP2680815A1 (en) 2014-01-08
BR112013020816A2 (pt) 2016-10-18
US20120225100A1 (en) 2012-09-06
PL2680815T3 (pl) 2017-02-28

Similar Documents

Publication Publication Date Title
MX341035B (es) Sustrato solido desintegrable poroso para aplicaciones para el cuidado personal.
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
JO3416B1 (ar) تركيبات مضادة للبكتيريا وطرق استخدامها
IT1399202B1 (it) Metodo per la produzione di manufatti elastomerici funzionalizzati e manufatti cosi' ottenuti
PH12013501143A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
UA86731C2 (ru) Делимая галеновая форма модифицированного высвобождения активного ингредиента
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
IN2014MN00859A (es)
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
PL2768935T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
SMT201600166B (it) Processi per la produzione di un agente farmaceuticamente attivo
EP2413951A4 (en) FORMULATION FOR GENERATING A WIDE REACTIVE NEUTRALIZATION OF HIV ANTIBODIES
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
ECSP11011483A (es) Piperidinas sustituidas
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
MY152040A (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
CU20110214A7 (es) Piperidinas sustituidas
IN2012DN00763A (es)
MX2014001862A (es) 5-cicloalquil-o 5-heterociclil-nicotinamidas.

Legal Events

Date Code Title Description
FG Grant or registration